# Neurocrine Biosciences Inc: Form DEF 14A, filed Apr 10, 2024

- Company: [Neurocrine Biosciences Inc](/companies/nbix.md) (CIK 914475)
- Form: DEF 14A
- Filed: 2024-04-10
- Accepted by EDGAR: Apr 10, 2024, 16:07 ET
- Period: 2024-05-22
- Accession: 0000914475-24-000106
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/914475/000091447524000106/nbix-20240409.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/914475/000091447524000106/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/914475/000091447524000106/nbix-20240409.htm

Filed Apr 10, 2024.
Source: SEC EDGAR, the filing index for accession 0000914475-24-000106. Last ingested by Listed: Nov 3, 2026, 22:38 ET. No prices; not investment advice.